close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novamind Inc (OP:NVMDF)

N/A UNCHANGED
Last Price Updated: 3:36 PM EDT, Jun 13, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Novamind Inc

< Previous 1 2 Next >
News headline image
National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000 ↗
The U.S. government has taken a significant step toward tackling the mounting national substance addiction crisis by partnering with neuroscience company Delix Therapeutics... 
Via Benzinga
Topics Death
News headline image
Novamind Opens Addiction Clinic In Utah, Establishing Substance Use Disorder Program ↗
Novamind Inc. (OTCQB:NVMDF),... 
Via Benzinga
News headline image
Novamind Partners With Bienstar Wellness, Opening Door To Ibogaine Treatment For Addiction Disorders ↗
Novamind Inc. (OTCQB:NVMDF) a mental health compan... 
Via Benzinga
News headline image
Psychedelic Medicine: Major Health Providers Including Blue Cross Now Cover Ketamine Treatments ↗
Four major health insurance providers recently approved psychedelic medicine company Novamind Inc. (CSE: 
Via Benzinga
News headline image
Compass Pathways Phase II Results: A Disappointment For Some, An Opportunity For Others ↗
Compass Pathways reported 
Via Talk Markets
News headline image
Compass Pathways 2.0: A New Rally In Psychedelic Stocks? ↗
Compass Pathways' IPO sparked a sector-wide rally in 2020. Now CMPS is on the move again. Is history about to repeat? 
Via Talk Markets
Topics Initial Public Offering
News headline image
Psychedelics Industry Moving Full-Speed Ahead, When Will Stocks Catch Up? ↗
The psychedelic drug industry is advancing by leaps and bounds, but the stocks have been sliding. Why this disconnect won't last. 
Via Talk Markets
News headline image
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation ↗
The Week In Psychedelics 
Via Benzinga
News headline image
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are ↗
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... 
Via Benzinga
News headline image
Psyched: Seattle Decriminalizes Psychedelics, Psilocybin Increases Emotions From Music, Novamind's Palliative Care Program ↗
The Week In Psychedelics 
Via Benzinga
News headline image
Psychedelic Medicine For End-Of-Life And Palliative Care Patients: Novamind Launches Treatment Program ↗
Novamind (Canadian: NM) (OTCQB:NVMDF), a company in the ps... 
Via Benzinga
News headline image
Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction ↗
The Week In Psychedelics: 
Via Benzinga
News headline image
Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry? ↗
By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate... 
Via Benzinga
News headline image
Psychedelic Drug Industry Report Card For 2021 ↗
In assessing the psychedelic drug industry, a primary focus for investors is drug development. 
Via Talk Markets
News headline image
Which Psychedelic Drug Has The Most Commercial Potential? ↗
As the Mental Health Crisis has become a mental health pandemic, clinical research on psychedelic drugs is showing that these substances are the best – and only – option to address this crisis. 
Via Talk Markets
News headline image
Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected ↗
Last week in Psychedelics: 
Via Benzinga
News headline image
Psyched: Atai's $214M IPO, MindMed CEO Resigns, Field Trip Applies To Nasdaq, Cybin And Novamind Target Frontline Health Workers ↗
Atai Launches $214 Million Nasdaq IPO Offering Psychedelics biotech platform Atai life Sciences has announced an initi... 
Via Benzinga
Topics Initial Public Offering
News headline image
Video: Experts Discuss Use Of Psychedelics In Mental Health Settings ↗
The psychedelics industry has started to gain serious traction and is attracting lots of attention these days. However, what many people may not kn... 
Via Benzinga
News headline image
Psyched: Groundbreaking Phase 3 Results On MDMA, Small Pharma, Wesana Go Public, Gilgamesh Raises $27M ↗
Last week, the psychedelics space was moved by results from the world’s first Phase 3 clinical study of a scheduled psychedelic compound... 
Via Benzinga
News headline image
Novamind And Field Trip Expand Footprint Of Psychedelic Clinics ↗
Novamind Inc. (OTC:NVMDF), a company specializing in mental ... 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today